Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
GHRP-6 (GHRP6) is a growth hormone peptide, at the clinical trials stage in the published literature. Growth Hormone Releasing Peptide-6, the first generation GHRP known for its potent GH release and strong appetite stimulation.
Growth Hormone Releasing Peptide-6, the first generation GHRP known for its potent GH release and strong appetite stimulation.
| Research Status | Clinical trials |
|---|---|
| Half-Life | 15-30 minutes |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | 100-300 mcg |
Ghrelin mimetic that stimulates GH release and significantly increases appetite through ghrelin pathway activation.
Growth Hormone Releasing Peptide-6, the first generation GHRP known for its potent GH release and strong appetite stimulation.
Ghrelin mimetic that stimulates GH release and significantly increases appetite through ghrelin pathway activation.
GHRP-6 is at the following stage in the published literature: Clinical trials. All information is for research and educational purposes only.
Reported half-life: 15-30 minutes.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.